查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012909

血液採集管市場：按管型、材質、應用和最終用戶分類－2026-2032年全球市場預測

Blood Collection Tubes Market by Tube Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年血液採集管市場價值為 44 億美元，預計到 2026 年將成長至 46.4 億美元，複合年成長率為 7.33%，到 2032 年將達到 72.3 億美元。

主要市場統計數據
基準年 2025 44億美元
預計年份：2026年 46.4億美元
預測年份 2032 72.3億美元
複合年成長率 (%) 7.33%

對採血管市場進行簡要概述，重點關注影響當前行業趨勢的技術、臨床和供應鏈因素。

血液採集管路市場處於臨床實踐、檢查室工作流程最佳化和法律規範交匯的十字路口。管路化學、檢體穩定化和分離介質的進步，不斷改進臨床醫生和實驗室技術人員對分析前品質控制的方法。同時，生產規模的擴大和材料科學的進步，也推動產品選擇和物流的持續變革。此外，日益成長的分散式檢查和即時檢測的需求，促使製造商調整檢體設計，優先考慮產品的穩健性、易用性和與自動化處理系統的兼容性。所有這些因素共同作用，使得分析前變數在診斷準確性和操作效率方面變得愈發重要。

材料科學、自動化相容性和永續性的日益重視如何重塑試管選擇、工作流程和供應商策略。

血液採集管市場正經歷變革性的轉變，這主要得益於材料創新、與自動化系統的兼容性以及分散式檢查的擴展。塑膠聚合物複合技術日益成熟，其耐用性、降低破損風險以及與離心和自動化系統的兼容性均已達到傳統玻璃管的水平，從而重塑了採購偏好。同時，分離介質和抗凝血劑化學成分的改進延長了檢體的穩定性，並提高了下游分子和生化檢測的準確性。這使得管路設計作為臨床品質的決定性因素顯得尤為重要。除了這些技術變革之外，與檢查室自動化系統的整合也在不斷推進，促使管路形狀和條碼系統走向標準化，從而加快處理速度並減少人為錯誤。

關稅的累積波動如何促進了整個供應鏈中更具韌性的採購、更嚴格的供應商選擇以及庫存策略的調整？

近期關稅政策的變化對採血管供應鏈產生了多方面的影響，顯著影響了採購決策、成本結構和採購計畫。關稅帶來的成本壓力促使相關人員重新評估地理採購地點，加快供應商多元化策略，並探索近岸外包方案，以降低進口關稅和跨境物流中斷的風險。為此，一些製造商正在最佳化製造地，並實現關鍵零件的在地化生產，以在確保醫療設備符合監管要求的同時，保持競爭力。

從綜合細分觀點展示管材化學性質、材料科學、應用要求和最終用戶背景如何決定採購和驗證的優先事項。

細分市場分析揭示了產品設計、材料選擇、應用和最終用戶場景如何相互交織，共同塑造需求模式和營運要求。根據管材類型，市場涵蓋了具有特殊化學成分和形狀的各種產品，例如檸檬酸鹽管、EDTA管、葡萄糖管、肝素管、血漿分離管 (PST) 和血清分離管 (SST)。每種管材都旨在滿足特定的分析物和分析前穩定性目標。因此，採購決策會受到檢測組合、處理能力要求以及與下游製程相容性的影響。就材料而言，玻璃管和塑膠管之間的權衡需要兼顧檢體完整性、破損風險、自動化相容性和環境生命週期影響等因素，這促使許多機構不僅評估單價，還評估總擁有成本。

影響全球市場籌資策略、本地生產和產品系列差異化的區域趨勢和監管細微差別。

區域趨勢帶來了獨特的機會和營運限制，這些因素影響著供應鏈設計、監管參與以及導管創新產品的採用率。在美洲，成熟的檢查室網路和龐大的醫院系統推動了對導管的強勁需求，這些導管既支援高通量臨床診斷，也支援血庫運作。法律規範強調醫療設備註冊、可追溯性和品管系統。因此，服務該地區的供應商專注於認證、國內經銷夥伴以及物流解決方案，以確保分散式醫療保健網路的連續性。相較之下，歐洲、中東和非洲（EMEA）地區的監管和經濟環境則呈現多樣性。西歐市場通常優先考慮環境永續性和符合ISO標準的品管體系，而該地區的新興市場則更注重成本效益高的解決方案和擴充性的分銷模式。這些差異促使供應商採取雙軌制策略，在高級產品產品線和成本績效型產品線之間取得平衡。

創新、品質系統、在地化生產和策略夥伴關係如何重塑採血管供應商的競爭優勢。

主要企業之間的競爭格局由產品創新、法規遵循、生產規模和策略夥伴關係共同塑造。投資先進試管化學、改進的分離技術和自動化就緒型設計的公司，往往能為臨床和分子診斷客戶提供差異化的價值提案。同時，擁有嚴格品管系統和改善供應商篩選流程的公司，能夠減少客戶檢驗中的阻力，成為醫療保健採購的首選。與自動化供應商和實驗室服務供應商建立策略夥伴關係，透過檢驗互通性，擴大市場覆蓋範圍並加速產品應用。

製造商和買家面臨的實際策略挑戰是，如何增強整個價值鏈的韌性、監管合應對力和臨床互通性。

產業領導企業可以透過調整產品開發、採購和營運實踐，使其與當前的臨床和供應鏈實際情況相符，從而採取多項切實可行的措施來鞏固其市場地位。優先投資於能夠經實踐驗證可提高檢體穩定性和自動化相容性的材料和分離介質，並確保這些創新擁有可靠的檢驗數據支持，以便客戶能夠將其整合到檢查室驗收流程中。除了產品創新之外，還應建立透明的供應商選擇框架和靈活的合約條款，以便在政策變更和物流中斷的情況下快速調整採購流程。在採購方面，應優先選擇包含服務水準承諾、可追溯性和可預測前置作業時間保證的契約，以確保供應的連續性。

我們透明且可重複的研究途徑，結合了與關鍵相關人員的訪談、產品檢驗和供應鏈映射，為策略洞察提供了支持。

本調查方法整合了對關鍵相關人員的訪談、產品層面的技術評估以及供應鏈分析，以得出可靠且基於證據的結論。初步研究包括與實驗室經理、採購負責人、製造工程師和品質保證專家進行結構化對話，以了解營運重點、驗證限制以及對供應商績效的看法。隨後，將這些定性見解與管材、抗凝血劑化學成分和分離介質的技術評估進行比較，以評估其與自動化平台和檢測流程的兼容性。

最終的綜合分析強調，需要將技術卓越性、營運適應性和積極主動的價值鏈管理相結合，以實現永續的臨床價值。

總而言之，血液採集管產業正受到多種因素的共同影響而發生重塑：材料創新、與自動化技術的融合、更嚴格的監管以及供應鏈的韌性。這些因素正在重塑不同終端使用者的採購標準，促使供應商在技術效能、運作可靠性和環境因素之間尋求平衡。隨著檢查室和醫療系統不斷提升分析前品質和工作流程效率，血液採集管的設計和供應商的實踐將在診斷準確性和處理能力方面發揮核心作用。同時，貿易政策的變化和區域製造業的發展趨勢凸顯了供應商策略多元化和在地化能力的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：採血管市場－依採血管類型分類

  • 檸檬酸管
  • EDTA管
  • 葡萄糖管
  • 肝素管
  • 血漿分離管（PST）
  • 血清分離管（SST）

第9章：採血管市場：依材料分類

  • 玻璃管
  • 塑膠管

第10章：採血管市場：依應用領域分類

  • 血庫
  • 臨床診斷
  • 法醫學
  • 分子診斷
  • 研究與開發

第11章：採血管市場：依最終用戶分類

  • 血庫
  • 測試機構
  • 居家醫療環境
  • 醫院
  • 研究機構

第12章：採血管市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：採血管市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：採血管市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國採血管市場

第16章：中國採血管市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AdvaCare Pharma
  • Becton, Dickinson & Company
  • Biosigma SpA
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • CML BIOTECH LIMITED
  • Convergent Technologies GmbH
  • Corning Incorporated
  • FL Medical SRL
  • Greiner Bio One International Gmbh
  • Haemonetics Corporation
  • Labtech Srl
  • Medline Industries, Inc.
  • Medtronic plc
  • Merck KGaA.
  • Micsafe Medical Group
  • Nanjing Vazyme Medical Technology Co., Ltd.
  • Nipro Medical Corporation
  • QIAGEN NV
  • Radiometer Medical ApS
  • SARSTEDT AG & Co. KG
  • Simport, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific
Product Code: MRR-437D4595813C

The Blood Collection Tubes Market was valued at USD 4.40 billion in 2025 and is projected to grow to USD 4.64 billion in 2026, with a CAGR of 7.33%, reaching USD 7.23 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.40 billion
Estimated Year [2026] USD 4.64 billion
Forecast Year [2032] USD 7.23 billion
CAGR (%) 7.33%

A concise foundational overview of the blood collection tubes landscape highlighting technological, clinical and supply-chain factors shaping current industry dynamics

The blood collection tubes landscape sits at the intersection of clinical practice, laboratory workflow optimization, and regulatory oversight. Advances in tube chemistry, sample stabilization, and separation media have refined how clinicians and laboratorians approach pre-analytical quality, while manufacturing scale and materials science have driven ongoing shifts in product selection and logistics. In parallel, rising demand for decentralized testing and point-of-care sample collection has prompted manufacturers to adapt designs for robustness, ease of use, and compatibility with automated handling systems. These converging forces have elevated the importance of pre-analytical variables in diagnostic accuracy and operational throughput.

Consequently, decision-makers across hospitals, diagnostic laboratories, research institutions, and blood banks are re-evaluating procurement specifications, supplier relationships, and validation protocols. Regulatory bodies continue to emphasize traceability, biocompatibility, and sterility, which in turn influence materials choices and supplier qualification practices. Moreover, environmental and sustainability considerations are increasingly informing material selection and packaging strategies, prompting a redesign of lifecycle approaches. Overall, the introduction sets the stage for a deeper understanding of technological trends, clinical drivers, and supply-chain imperatives that inform strategic planning for stakeholders across the diagnostics ecosystem.

How advances in materials science, automation compatibility, and sustainability priorities are reshaping tube selection, workflows, and supplier strategies

The blood collection tubes market is experiencing transformative shifts driven by innovation in materials, automation compatibility, and the expansion of decentralized testing. Plastic polymer formulations have matured to the point where durability, reduced breakage risk, and compatibility with centrifugation and automation now rival traditional glass tubes, reshaping procurement preferences. At the same time, enhanced separation media and anticoagulant chemistries are extending sample stability windows and enabling more accurate downstream molecular and biochemical assays, which strengthens the role of tube design as a determinant of clinical quality. These technological shifts are complemented by increasing integration with laboratory automation suites, where tube geometries and barcode systems are standardized to accelerate processing and reduce manual handling errors.

Operationally, laboratories are prioritizing pre-analytical quality controls and staff training to reduce variability, while manufacturers prioritize interoperability with automated systems and supply continuity. Environmental sustainability represents an additional driver of change, motivating material science innovations and packaging redesigns to reduce single-use plastics and optimize transport efficiency. Taken together, these transformational trends indicate a sector moving toward higher reliability, automation readiness, and environmental accountability, with implications for procurement strategies and regulatory compliance.

How cumulative tariff shifts have driven resilient sourcing, supplier qualification rigor, and inventory strategy adjustments across the supply chain

Recent tariff policy developments have exerted a multifaceted influence on the blood collection tubes supply chain, with pronounced effects on sourcing decisions, cost structures, and procurement timelines. Tariff-induced cost pressures have prompted stakeholders to reassess geographic sourcing footprints, accelerate supplier diversification strategies, and explore nearshoring options to mitigate exposure to import duties and cross-border logistical disruption. In response, some manufacturers have optimized manufacturing footprints or localized key components to preserve competitiveness while maintaining regulatory conformity for medical devices.

Beyond direct cost implications, tariffs have altered inventory management practices and contracting terms. Procurement teams have increased emphasis on flexible contract clauses, extended lead-time planning, and strategic safety stocks to absorb episodic tariff adjustments or trade policy shifts. Regulatory compliance considerations, including device registration and labeling requirements, complicate rapid supplier substitutions, thereby magnifying the need for robust supplier qualification processes. Furthermore, tariff-driven supplier realignment can affect quality control consistency and validation workflows, which necessitates a rigorous testing regime when introducing alternative tube types or materials. Ultimately, the cumulative impact has been to accelerate a shift toward more resilient, geographically balanced supply chains and to elevate supply-chain risk management as a board-level priority.

Integrated segmentation view demonstrating how tube chemistry, material science, application needs, and end-user contexts determine procurement and validation priorities

Segmentation insights reveal how product design, material choices, applications, and end-user contexts intersect to shape demand patterns and operational requirements. Based on tube type, the market includes specialty chemistries and format differentiation across Citrate Tubes, EDTA Tubes, Glucose Tubes, Heparin Tubes, Plasma Separation Tubes (PST), and Serum Separation Tubes (SST), each tailored to specific analytes and pre-analytical stability objectives; consequently procurement decisions hinge on assay portfolios, throughput requirements, and downstream processing compatibility. Based on material, the trade-offs between Glass Tubes and Plastic Tubes require balancing considerations of sample integrity, breakage risk, compatibility with automation, and environmental lifecycle impacts, prompting many institutions to evaluate total-cost-of-ownership rather than unit price alone.

Based on application, divergent needs emerge across Blood Banking, Clinical Diagnostics, Forensic, Molecular Diagnostics, and Research & Development, with clinical diagnostics and molecular workflows increasingly valuing tubes that support nucleic acid preservation and contamination control. Based on end user, differences in operational scale and regulatory oversight manifest across Blood Banks, Diagnostic Laboratories, Home Care Settings, Hospitals, and Research Institutions; for example, home care contexts prioritize ease of use and stability under variable transport conditions, whereas high-throughput diagnostic laboratories prioritize automation compatibility and barcode traceability. Taken together, these segmentation layers underscore the importance of aligning procurement and validation protocols with the specific analytical and operational requirements of each use case.

Regional dynamics and regulatory nuances shaping procurement strategies, localized manufacturing, and product portfolio differentiation across global markets

Regional dynamics present distinct opportunities and operational constraints that influence supply-chain design, regulatory engagement, and adoption rates for tube innovations. In the Americas, mature laboratory networks and extensive hospital systems drive robust demand for tubes that support both high-throughput clinical diagnostics and blood banking operations, while regulatory frameworks emphasize device registration, traceability, and quality systems. Consequently, suppliers serving this region focus on certification, domestic distribution partnerships, and logistics solutions to maintain continuity across dispersed healthcare networks. Conversely, Europe, Middle East & Africa exhibits a heterogeneous regulatory and economic landscape; Western European markets often prioritize environmental sustainability and ISO-aligned quality systems, while emerging markets within the broader region place stronger emphasis on cost-effective solutions and scalable distribution models. These distinctions encourage suppliers to adopt dual-tier strategies that balance premium product lines with value-oriented offerings.

Asia-Pacific is characterized by rapid expansion of diagnostic infrastructure, rising domestic manufacturing capabilities, and diverse clinical needs across urban and rural settings, driving demand for both advanced tube chemistries and ruggedized formats suitable for decentralized testing. Manufacturers operating in this region frequently invest in localized production and regulatory alignment to improve responsiveness and reduce lead times. Across all regions, cross-border logistics, regulatory harmonization efforts, and sustainability commitments are shaping long-term supplier strategies and partnership models.

How innovation, quality systems, localized manufacturing, and strategic partnerships are reshaping competitive advantage among blood collection tube suppliers

Competitive dynamics among leading companies are shaped by a mix of product innovation, regulatory compliance, manufacturing scale, and strategic partnerships. Firms investing in advanced tube chemistries, improved separation technologies, and automation-compatible designs tend to secure differentiated value propositions for clinical and molecular diagnostics customers. At the same time, companies that demonstrate rigorous quality management systems and robust supplier qualification processes reduce friction in customer validations and earn preference in institutional procurement. Strategic partnerships with automation vendors and laboratory service providers extend market reach and accelerate adoption through validated interoperability.

Manufacturing agility and supply-chain resilience also serve as decisive competitive factors, particularly for companies that can offer localized production, diversified component sourcing, and scalable capacity. Additionally, investments in sustainability initiatives, recyclable materials research, and reduced packaging footprints resonate with healthcare systems prioritizing environmental stewardship. Mergers, acquisitions, and strategic alliances further reconfigure the competitive landscape by integrating complementary capabilities such as reagent development, device interoperability, or distribution networks. Overall, competitive advantage accrues to organizations that combine technical innovation with supply-chain reliability, regulatory expertise, and customer-centric service models.

Practical strategic imperatives for manufacturers and buyers to enhance resilience, regulatory readiness, and clinical interoperability across the value chain

Industry leaders can take several pragmatic steps to strengthen their market positions by aligning product development, procurement, and operational practices with prevailing clinical and supply-chain realities. Prioritize investments in materials and separation media that demonstrably enhance sample stability and automation compatibility, and ensure those innovations are supported by robust validation data that customers can integrate into their laboratory acceptance protocols. Complement product innovation with transparent supplier qualification frameworks and flexible contract terms that allow rapid reconfiguration of sourcing in response to policy changes or logistical disruptions. In procurement, favor agreements that embed service-level commitments, traceability, and predictable lead-time assurances to safeguard continuity of supply.

Operationally, invest in comprehensive training programs and standardized pre-analytical procedures to reduce variability across collection sites and strengthen test reliability. Embrace sustainability as both a design criterion and a procurement metric, highlighting lifecycle impacts and recyclability in supplier evaluations. Finally, cultivate collaborative relationships with automation vendors, lab networks, and clinical stakeholders to co-develop validated solutions that reduce adoption friction. Implementing these recommendations will enhance resilience, regulatory readiness, and long-term value for stakeholders across the diagnostics ecosystem.

A transparent and reproducible research approach combining primary stakeholder interviews, product verification, and supply-chain mapping to underpin strategic insights

The research methodology synthesizes primary stakeholder interviews, product-level technical assessments, and supply-chain mapping to ensure robust, evidence-based conclusions. Primary research comprised structured conversations with laboratory directors, procurement officers, manufacturing engineers, and quality assurance professionals to capture operational priorities, validation constraints, and supplier performance perceptions. These qualitative insights were triangulated with technical evaluations of tube materials, anticoagulant chemistries, and separation media to assess compatibility with automation platforms and assay workflows.

Additionally, supply-chain mapping identified manufacturing footprints, logistics chokepoints, and regulatory registration pathways that influence sourcing decisions. The approach included targeted desk research on regulatory guidance, industry standards, and published clinical best practices to contextualize interview findings. Validation steps comprised cross-checking supplier claims against product specifications, packaging and transport protocols, and independently reported stability studies where available. Together, these methods provide a transparent and reproducible basis for the strategic insights and recommendations presented in the report.

Final synthesis highlighting the imperative to align technical excellence, operational adaptability, and proactive supply-chain management for sustained clinical value

In sum, the blood collection tubes domain is being redefined by converging forces: material innovation, automation integration, regulatory rigor, and supply-chain resilience. These forces are reshaping procurement criteria across diverse end users and driving suppliers to balance technical performance with operational reliability and environmental stewardship. As laboratories and healthcare systems continue to emphasize pre-analytical quality and workflow efficiency, tube design and supplier practices will play a central role in diagnostic accuracy and throughput. Concurrently, trade policy shifts and regional manufacturing dynamics underscore the value of strategic supplier diversification and localized capabilities.

Moving forward, stakeholders who integrate rigorous validation, close collaboration with automation partners, and sustainability considerations into procurement and product development will be best positioned to mitigate risk and deliver consistent clinical value. The cumulative message is clear: success in this sector depends on aligning technical excellence with operational adaptability and proactive supply-chain management to meet evolving clinical demands and regulatory expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Collection Tubes Market, by Tube Type

  • 8.1. Citrate Tubes
  • 8.2. EDTA Tubes
  • 8.3. Glucose Tubes
  • 8.4. Heparin Tubes
  • 8.5. Plasma Separation Tubes (PST)
  • 8.6. Serum Separation Tubes (SST)

9. Blood Collection Tubes Market, by Material

  • 9.1. Glass Tubes
  • 9.2. Plastic Tubes

10. Blood Collection Tubes Market, by Application

  • 10.1. Blood Banking
  • 10.2. Clinical Diagnostics
  • 10.3. Forensic
  • 10.4. Molecular Diagnostics
  • 10.5. Research & Development

11. Blood Collection Tubes Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Home Care Settings
  • 11.4. Hospitals
  • 11.5. Research Institutions

12. Blood Collection Tubes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Blood Collection Tubes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Blood Collection Tubes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Blood Collection Tubes Market

16. China Blood Collection Tubes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. AdvaCare Pharma
  • 17.7. Becton, Dickinson & Company
  • 17.8. Biosigma S.p.A.
  • 17.9. Bio-Rad Laboratories, Inc.
  • 17.10. Cardinal Health, Inc.
  • 17.11. CML BIOTECH LIMITED
  • 17.12. Convergent Technologies GmbH
  • 17.13. Corning Incorporated
  • 17.14. FL Medical S.R.L.
  • 17.15. Greiner Bio One International Gmbh
  • 17.16. Haemonetics Corporation
  • 17.17. Labtech S.r.l.
  • 17.18. Medline Industries, Inc.
  • 17.19. Medtronic plc
  • 17.20. Merck KGaA.
  • 17.21. Micsafe Medical Group
  • 17.22. Nanjing Vazyme Medical Technology Co., Ltd.
  • 17.23. Nipro Medical Corporation
  • 17.24. QIAGEN N.V.
  • 17.25. Radiometer Medical ApS
  • 17.26. SARSTEDT AG & Co. KG
  • 17.27. Simport, Inc.
  • 17.28. Terumo Corporation
  • 17.29. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD COLLECTION TUBES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD COLLECTION TUBES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY CITRATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY CITRATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY CITRATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY EDTA TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GLUCOSE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GLUCOSE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GLUCOSE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY HEPARIN TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY PLASMA SEPARATION TUBES (PST), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY PLASMA SEPARATION TUBES (PST), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY PLASMA SEPARATION TUBES (PST), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY SERUM SEPARATION TUBES (SST), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY SERUM SEPARATION TUBES (SST), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY SERUM SEPARATION TUBES (SST), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GLASS TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GLASS TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GLASS TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY PLASTIC TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY PLASTIC TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY PLASTIC TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY BLOOD BANKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY BLOOD BANKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY BLOOD BANKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY FORENSIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY FORENSIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY FORENSIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS BLOOD COLLECTION TUBES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GCC BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GCC BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. GCC BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. GCC BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GCC BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. G7 BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. G7 BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. G7 BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. G7 BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. G7 BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. NATO BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. NATO BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NATO BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. NATO BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NATO BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD COLLECTION TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA BLOOD COLLECTION TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA BLOOD COLLECTION TUBES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA BLOOD COLLECTION TUBES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA BLOOD COLLECTION TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA BLOOD COLLECTION TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)